title: Preserving LXR by inhibiting T39: A step closer to treating atherosclerosis and steatohepatitis?
authors.affiliation: Department of Physiology and Neurobiology and the Institute for Systems Genomics, University of Connecticut, Storrs, CT.
authors.forename: Melanie
authors.initials: M
authors.lastname: Tran
authors.affiliation: Department of Physiology and Neurobiology and the Institute for Systems Genomics, University of Connecticut, Storrs, CT.|Veterans Affairs Connecticut Healthcare System, West Haven, CT.|Department of Internal Medicine, Section of Digestive Diseases, Yale University, New Haven, CT.|School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
authors.forename: Li
authors.initials: L
authors.lastname: Wang
mesh_terms: D050197:Atherosclerosis; D005234:Fatty Liver; D006801:Humans